Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation

RSC Adv. 2020 Jan 31;10(9):4927. doi: 10.1039/d0ra90007a. eCollection 2020 Jan 29.

Vegard Torp Lien¹, Margrethe Konstanse Kristiansen¹, Solveig Pettersen², Mads Haugland Haugen², Stefan Krauss^{3

4}, Dag Erlend Olberg^{1

5}, Jo Waaler^{3

4}, Jo Klaveness¹

¹ Department of Pharmacy, University of Oslo Oslo Norway v.t.lien@farmasi.uio.no.
² Department of Tumor Biology, Institute for Cancer Research, OUS Radiumhospitalet Oslo Norway.
³ Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo Oslo Norway.
⁴ Department of Immunology and Transfusion Medicine, Oslo University Hospital Oslo Norway.
⁵ Norsk Medisinsk Syklotronsenter AS, OUS Rikshospitalet Oslo Norway.

Abstract

[This corrects the article DOI: 10.1039/C9RA08954C.].